Drug Shortage Report for SANDOZ FESOTERODINE FUMARATE

Last updated on 2024-09-09

Report ID 236045
Drug Identification Number 02521776
Brand name SANDOZ FESOTERODINE FUMARATE
Common or Proper name FESOTERODINE FUMARATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FESOTERODINE FUMARATE
Strength(s) 8MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 30PRT
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-08-27
Estimated end date 2024-09-06
Actual end date 2024-09-09
Shortage status Resolved
Updated date 2024-09-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-09-09 French Compare
v4 2024-09-09 English Compare
v3 2024-08-28 English Compare
v2 2024-08-27 French Compare
v1 2024-08-27 English Compare

Showing 1 to 5 of 5